Articles about 'Cambridge Stem Cell Institute'

Centre for Children's Gut Health aims to transform the physical and mental health of children and young people.

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease, a study in mice has suggested. Further research in clinical trials will be needed to confirm this works for patients.

Two University of Cambridge researchers are among the thirty-two early career researchers, tackling issues from improving food security to developing better medical implants, who have been announced as the 2025 Schmidt Science Fellows.

Meet the winner of the Cambridge Awards 2024 for Research Impact and Engagement and learn more about their projects.

Cambridge researchers are developing implants that could help repair the brain pathways damaged by Parkinson’s disease.

The Human Cell Atlas is an ambitious project to map every cell in the human body. Its co-lead, Professor Sarah Teichmann, explains how the initiative is already changing our understanding of our bodies.

Professor David Rowitch, Head of the Department of Paediatrics at the University of Cambridge, has been elected to the prestigious National Academy of Medicine in the USA.

Researchers have discovered a way to extend the shelf life of blood stem cells outside the body for use in gene therapy, providing patients with better options and improving their outcomes.

A unique, free new game – “part Sims, part Tamagotchi” – lets players inhabit a stem cell researcher as they rise through the ranks: growing cells, scientific collaborations, and reputation.